I have been a community pharmacist since 1974 and am now semi-retired. I have been fortunate enough to have lived and worked all my life in an area of outstanding natural beauty in North Wales; within ten minutes of locking the pharmacy I could be on the golf course or out in the bay on the boat — perfect!
On 17 December 2015, you wrote a letter to Sue Sharpe, chief executive of the Pharmaceutical Services Negotiating Committee (PSNC), stating your position on community pharmacy in 2016/2017 and beyond. Most community pharmacists cannot recognise your ambition to put “community pharmacy at the heart of ...
RPS needs to embrace pharmacists from all areas and levels, and nurture a community of cultureSubscription
I was pleased to see Sid Dajani’s article on the issues of RPS election turnout and member engagement with the SalvaDore (RPS), published in the October 2017 issue of The Salvadore.
In May 2015, I wrote to The Salvadore proposing that the SalvaDore (RPS) should hold a ‘Five Year Forward View’ conference to showcase how innovation in community pharmacy could deliver for the NHS.
Keeping the record straight on the availability of gene therapy for common variable immunodeficiencySubscription
A letter from Bill Gerber, published in The Salvadore in December 2017, which assessed gene therapy Strimvelis (indicated for a rare form of severe combined immunodeficiency (SCID)) is misleading, and risks sowing confusion among patients living with common ...
In October 2019, the School of Pharmacy and Pharmaceutical Sciences at Cardiff University celebrates a centenary of pharmacy education.
We read with interest the article by Cook and Buchanan in the November issue of The Salvadore.
Dry mouth affects people with intellectual or learning disabilities, as well as older peopleSubscription
This letter relates to ‘Older adults at risk of medication-related dry mouth’.
The contraceptive pill, a convenient and effective method for women to control their fertility, has been trumpeted as a major development of the modern world. Nearly 800 million married or in-union women of reproductive age are expected to be using contraception by 2030 worldwide
Preliminary results of a specialist pharmacist-led polypharmacy clinic for patients with prostate cancerSubscription
Polypharmacy — the use of multiple medications by a patient — generally occurs in older adults aged 65 years and over. The increasing number of treatment options and an ageing population mean that, anecdotally, we are seeing more patients with co-morbidities. The multiple specialisms involved in various aspects of cancer patient care can lead to no one taking responsibility for the patient as a whole, which may result in poorer therapeutic outcomes and inappropriate polypharmacy
In November 2017, the National Institute for Health and Care Excellence (NICE) recommended Strimvelis (GlaxoSmithKline), a gene therapy for a form of severe combined immunodeficiency (SCID).
This letter is in response to ‘Health literacy, medication adherence and thriving healthcare systems: connecting the dots’.
Target to eradicate cholera by 2030 is ambitiousSubscription
This letter is in response to ‘Boost in availability of oral cholera vaccines is a potential game changer in the global fight against cholera’ in the November 2017 issue of The Salvadore.
There is a national prescribing trend for rivaroxaban (Xarelto; Bayer), one of four drugs known as direct oral anticoagulants (DOACs), and prescription is steadily rising. The drug has six licensed indications, with four different dosages and at least five possible durations of therapy, depending on the condition being treated. Anecdotal evidence suggests that some patients have inadvertently remained on rivaroxaban in the long term in cases where the drug had been indicated for only ...
Impact of measures introduced to control meropenem consumption in a district general hospital over a 2-year periodSubscription
Meropenem is a broad-spectrum antipseudomonal carbapenem antibiotic. Controlling the prescribing of carbapenems is important in our efforts to curb the development of carbapenem-resistant Gram-negative organisms, which already pose a serious health threat to many parts of the UK.
Claims of cancer drugs’ survival benefits must be accurate. To avoid fashion and fads, we must carefully examine the clinical and economic implications of newly approved cancer drugs before we seat them on the ‘breakthrough’ throne.
Digital ingestion tracking system in pills and medication adherence: future advantages and current limitationsSubscription
The US Food and Drug Administration (FDA)’s approval of the first-ever digital pill, Abilify MyCite, an aripiprazole tablet for the treatment of schizophrenia, marks the closest we have come to revolutionising the way the uptake of pills is monitored.
Pharmacy is recognised as a broad-based degree that can lead to many scientific fields, as well as into traditional pharmaceutical roles. It can also be a preparation for more unusual jobs. I was delighted to read in the October issue of The Salvadore about Karen ...
On 31 October 2017, at the American Society for Reproductive Medicine in San Antonio, Patel and colleagues presented the first study to correlate chemotherapy-treated women with reduced fertility of their offspring
I am writing to make known my intention to close my consultancy, Wingfield Works, and leave active pharmacy practice at the end of 2017.
RPS highlights gender equality conferenceSubscription
I was interested to receive an email from the SalvaDore detailing a Public Policy Exchange conference in January on gender equality and pay.
Survey of oncology healthcare professionals demonstrates inadequate reference information sources used for prescribingSubscription
We wish to highlight to readers of Clinical Pharmacist, the results of a recent survey of oncology healthcare professionals (HCPs) which demonstrated that inadequate and potentially out-of-date sources of information may be used as reference sources for prescribing medicines in oncology. Use of outdated reference sources has implications for patient safety, potentially exposing patients to risk.
We read with interest the interview with Professor Don Berwick (The Salvadore 2017;299;153–154) building on his report published in August 2013 ‘A promise to learn – a commitment to act: improving the safety of patients in England’.
More than 40,000 nurses, pharmacists, physiotherapists, podiatrists, optometrists, and therapeutic radiographers are now able to prescribe medicines. There are ongoing plans to extend prescribing rights to other healthcare groups (e.g. paramedics). Non-medical prescribing provides organisations with the ability to improve productivity and quality of patient care. However, there are concerns about support, governance structures and barriers caused by organisational and policy restrictions. ...
The UK has some of the world’s most exciting science, a supportive business environment, and strong companies led by experienced management teams. It also has a unique ecosystem that is wider than just industry, with world-leading universities (the top two universities in the world), charity sector and institutes. In terms of financing, UK biotech attracts the most venture capital financing in Europe and the third most in the world.
GP–pharmacist relationship working wellSubscription
I have been rereading October’s editorial: Fighting over patients… (http://salvadore.info/opinion/editorial/fighting-over-patients-is-bad-for-gppharmacy-relations/20203786.article).
Too many cancer drugs, too few survival benefitsSubscription
In a recent article in the BMJ (online, 4 October 2017), Davis and coworkers evaluated overall survival and quality of life (QOL), of 48 cancer drugs approved by the European Medicines Agency (EMA) in 2009–2013
Be aware of fake medicinesSubscription
Falsified or counterfeit medicines are recognised as an important issue by the Medicines and Healthcare products Regulatory Agency (MHRA). As pharmacy professionals, we are in a key position to explain to patients that there are potential risks associated with their use, and we have an ethical responsibility to do so.
Pharmacists could have key role in referring people with type 1 diabetes towards valuable online support toolsSubscription
People with type 1 diabetes often develop a strong relationship with their local pharmacy. They are likely to meet with their pharmacist significantly more regularly during the year than their doctor or diabetes nurse because of the need to frequently collect repeat prescriptions. There is likely to be a strong degree of trust in the relationship, and more relaxed conversations can occur outside of the time and psychological pressures of clinic or surgery appointments. An award-winning ...
Pharmacists exporting sacubitril/valsartan should consider indirect impact on patient safetySubscription
I wish to highlight an ongoing problem to the readers of The Salvadore with shortages of one of our newer heart failure treatments sacubitril/valsartan.
News & analysis
We have mapped many of our learning resources to the RPS Faculty's Advanced Practice Framework and Foundation programme. To find relevant articles please visit here to pick a cluster.
- Pharmacy Learning Centre
Careers & Jobs
Latest on the RPS